Katie B Shannon, LCSW | |
2224 1st Ave W Ste 4, Williston, ND 58801-6286 | |
(701) 572-3335 | |
Not Available |
Full Name | Katie B Shannon |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | 2224 1st Ave W Ste 4, Williston, North Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295862621 | NPI | - | NPPES |
54516 | Medicaid | ND | |
27774 | Other | ND | BLUE CROSS BLUE SHIELD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 3671 (North Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Katie B Shannon, LCSW 2224 1st Ave W Ste 4, Williston, ND 58801-6286 Ph: (701) 572-3335 | Katie B Shannon, LCSW 2224 1st Ave W Ste 4, Williston, ND 58801-6286 Ph: (701) 572-3335 |
News Archive
The presence of an immune-suppressing protein in non-cancerous immune cells may predict how patients with different types of cancer respond to treatment, a multi-center phase I study using an investigational immune therapy drug has found.
The embryo of a tiny, silvery tropical fish found in many home aquariums is providing cancer researchers at Northwestern University Feinberg School of Medicine with powerful new insights into the development of malignant melanoma, the deadliest form of skin cancer.
Two knee surgeons at University Hospitals Leuven have discovered a previously unknown ligament in the human knee. This ligament appears to play an important role in patients with anterior cruciate ligament tears.
Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH).
Janssen Research & Development, LLC today announced positive results from a pivotal Phase 2 global registration study (MCD2001) suggesting siltuximab, an investigational compound, along with best supportive care, exhibited statistically significant efficacy and a tolerable safety profile compared with placebo and BSC in treating patients with the rare disorder Multicentric Castleman's Disease who are HIV-negative and human herpes virus 8-negative.
› Verified 3 days ago
Mr. Terry L Goldade, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 316 2nd Ave W, Williston, ND 58801 Phone: 701-774-4600 Fax: 701-774-4620 | |
Linda L Larson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 316 2nd Ave W, Williston, ND 55880 Phone: 701-774-4600 Fax: 701-774-4620 | |
Theresa E Scully, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 125 Main St; Unit 220, Williston, ND 58801 Phone: 701-570-4602 | |
Charlotte O'keefe, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1500 14th St W, Suite 290, Williston, ND 58801 Phone: 701-334-6242 Fax: 701-713-3299 | |
Miss Donna Peterson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1500 14th St Sw, Suite 250, Williston, ND 58801 Phone: 701-334-6242 | |
Ms. Charell G Schillo, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 316 2nd Ave W, Williston, ND 58801 Phone: 701-774-4600 Fax: 701-774-4620 |